BETH LEWIS: Open Payments
NPI 1205457264 · JESUP, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,074 in 92 payments from 14 companies in 2025. Trend: 2023 $330 · 2024 $1,117 · 2025 $2,074
Food & beverage: $1,874Education: $200
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 16 | $319 |
| AstraZeneca Pharmaceuticals LP | 10 | $262 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $220 |
| Mallinckrodt Hospital Products Inc. | 7 | $211 |
| Inspire Medical Systems, Inc. | 10 | $196 |
| GlaxoSmithKline, LLC. | 10 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $151 |
| Verona Pharma, Inc. | 6 | $137 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| United Therapeutics Corporation | 4 | $95 |
Products named: DUPIXENT, LUMRYZ, ACTHAR, INSPIRE, GLASSIA, TRELEGY ELLIPTA, Ohtuvayre, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
